Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Seelos Therapeutics Inc. logo

Seelos Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.33
 
USD
  
-0.05
  
(-13.79%)
Optionable: Yes  Market Cap: 5 M  90-day average vol: 443,471

Previous close: 0.3851  Open: 0.3979  Bid: 0.3312  Ask: 0.38
52 week range    
0.33   
   49.80
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 18th April 2024
31
MarketXLS Rank
40
Value
30
Technical
23
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

SEEL Income Statement

Annual
Dec-12Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-37000.0
Basic EPS from continuing operations-12.0-0.43-0.73-0.69
Basic EPS total-12.0-0.43-0.73-0.69
Basic weighted shares outstanding915 M1 M1 M217222.0396400.025366.020 M45 M91 M106 M
Cost of sales-4 M-3 M-3 M
Depreciation-200000.0-100000.0-200000.0-100000.0-100000.0-40000.0
DepreciationAndAmortization-200000.0-100000.0-200000.0-100000.0-100000.0-40000.0
Diluted EPS total-34.8-14.7-16.5-34.2-2.52-0.43-0.73-0.69
Diluted normalized net income/share-12.0-0.69
Diluted weighted shares outstanding912959.01 M1 M217339.020 M45 M106 M
DilutedDiscontinuousOperations-6.9-0.90.630.3-0.9
Earnings from equity interest250000.0255000.050000.0
EarningsFromEquityInterestNetOfTax250000.0255000.050000.0
GainOnSaleOfPPE-1 M-14000.0-2000.0
GainOnSaleOfSecurity3 M846000.0
GainsLossOnDisposalOfDiscontinuedOperations-6 M-1 M691000.0
GeneralAndAdministrativeExpense15 M14 M11 M8 M7 M3 M8 M8 M15 M12 M
Gross operating profit4 M-120000.08 M6 M511000.0151000.0
ImpairmentOfCapitalAssets8 M
Income before tax-25 M-16 M-22 M-8 M-12 M-3 M-51 M-19 M-66 M-74 M
Income restructuring and M&A31771.0
Income taxes516000.0
Interest income-325000.0-727000.0-339000.0-983000.0-83000.0-160000.0-109000.045000.0113000.0121000.0
InterestExpenseNonOperating-100000.0-1000000.0-100000.0131000.029000.0164000.02 M14000.0
MiscOtherSpecialCharges175000.0158000.01 M7 M-991000.0223000.0-16 M-223000.0-3 M-3 M
Net income from total operations-32 M-17 M-22 M-8 M321000.0-3 M-51 M-19 M-66 M-74 M
NetIncomeCommonStockholders-32 M-17 M-22 M-8 M-12 M-3 M-51 M-19 M-66 M-74 M
NetIncomeContinuousOperations-32 M-17 M-22 M-8 M321000.0-3 M-51 M-19 M-66 M-74 M
NetIncomeDiscontinuousOperations-6 M-1 M691000.0226000.012 M-24000.0
NetNonOperatingInterestIncomeExpense-325000.0-727000.0-339000.0-983000.0-83000.0-291000.0-138000.0-119000.0-1 M107000.0
Normalized income-48 M-58 M
Operating income-17 M-19 M-24 M-14 M-11 M-3 M-35 M-19 M-62 M-71 M
Operating income before depreciation (EBITDA)-25 M-16 M-22 M-9 M-12 M-3 M-51 M-19 M-63 M-73 M
OperatingExpense-29 M-17 M-31 M-14 M-11 M-3 M-30 M19 M62 M71 M
Other income net-425000.0-4 M-2 M-7 M993000.0-223000.016 M223000.03 M3 M
Other special charges-500000.0-90000.0
OtherGandA15 M14 M11 M8 M7 M3 M8 M8 M15 M12 M
OtherImpairmentOfCapitalAssets-500000.0
OtherOperatingExpenses-155000.0-41000.0-34000.0461000.0-34000.0-13000.05 M100000.0100000.0100000.0
OtherWriteDown-200000.0
RentAndLandingFees15 M14 M11 M8 M7 M3 M8 M100000.0
Research & development expense5 M5 M21 M6 M3 M553000.023 M11 M47 M59 M
ResearchExpense5 M5 M21 M6 M3 M553000.023 M11 M47 M59 M
RestructringAndMnAIncome31771.0
Revenue per share-300000.0-500000.0-200000.0
SalariesAndWages-3 M-2 M-2 M-2 M-1 M-33000.0-459000.02 M8 M5 M
Selling Gen & administrative expense15 M14 M11 M8 M7 M3 M8 M8 M15 M12 M
Special income/charges-8 M90000.0
Total Income available for interest expense (EBIT)-25 M-16 M-23 M-9 M-12 M-3 M-51 M-19 M-64 M-74 M
Total common shares outstanding101141.0126242.0168048.0258059.0544627.0613533.037 M73 M4 M108 M
Total net income-32 M-17 M-22 M-8 M321000.0-3 M-51 M-19 M-66 M-74 M
Total ordinary shares14 M14 M14 M14 M14 M14 M14 M14 M14 M14 M
Total revenues8 M3 M9 M6 M511000.0151000.0
TotalExpenses-33 M-20 M-31 M-14 M-11 M-3 M-30 M19 M62 M71 M
TotalRevenue23000.021000.0769000.06 M511000.0375000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University